NYSE · BUR

Burford Capital Limited

$4.14 -$0.01 (-0.24%) 1D After hours

Key Metrics

$909.14M
Market cap
P/E · TTM
−$1.43B
Revenue · TTM
−$1.60B
Net income
EPS · TTM $-7.17
Dividend yield
Free cash flow −$321.12M
Beta · 1Y 1.68
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 17
    From its Feb 18 high, the share price fell 60%.

    Peak close $9.78 on Feb 18; trough close $3.92 on Jul 17. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -60%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 31
    The stock moved +12.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 31
  • Mar 27
    The stock moved -47.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 27

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$909.14M
Enterprise value$2.61B
Shares outstanding219.1M
52-wk range$3.59 – $14.14
Avg volume · 20D922.6K
Net cash −$1.70B
Book value / share$3.71
IndustryFinance Services
ExchangeNYSE
About Burford Capital Limited
IPO dateApr 15, 2013
Employees172

Burford Capital Ltd provides capital against the underlying value of litigation and legal assets, known as legal finance, serving the legal industry with financial products and services.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating 111.9%
Net 112.2%
FCF 22.5%
ROE / ROIC -98.6% · -63.2%

Financial Health

Current ratio
Quick ratio
Debt / equity2.90
Debt / EBITDA
Net cash −$1.70B
Working capital

Cash Flow · TTM

Operating CF −$320.82M
Capex −$301.00K
Free cash flow −$321.12M
Buybacks $3.65M
Dividends paid
Shareholder yield 0.4%

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

-1.3
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings